LJI Board of Directors welcomes four new members
Institute strengthens its leadership going into 2023
LJI scientists reflect on what it means to make the “Highly Cited” list
A record number of LJI researchers have been named to the 2022 list, including two early career scientists
The cells that never forget
’22 SPARK winner Gurupreet Singh Sethi, Ph.D., aims to change how the immune system "remembers" asthma triggers
Phosphorylation of Runx proteins controls thymocyte fate
Ichiro Taniuchi, M.D., Ph.D. 10-28-22 at La Jolla Institute for Immunology.
On the trail of missing genes and cancer clues
LJI scientists connect TET loss of function to missing genes in embryonic stem cells
Cecilia Lindestam Arlehamn wins WHAM Edge Award funding to study sex-based differences in Alzheimer’s and Parkinson’s diseases
Some neurological diseases show up more in men versus women. Researchers need to know why.
New Lassa fever therapy may be on the horizon
Three rare antibodies, combined in a "cocktail," are effective in fighting Lassa virus
Entry of Human Paramyxoviruses
Anne Moscona, M.D. 10-19-22 at La Jolla Institute for Immunology.
What it takes
LJI scientists shine a light into the depths of Alzheimer's disease
All creatures great and really, really small
“Zoonosis is everywhere. This is where pandemics come from."
Get to know Ferhat Ay, Ph.D., the chromosome cartographer
How computational biology is propelling the field of immunology
Online exclusive: The dengue problem
Researchers set out to develop a dengue virus vaccine 80 years ago. We still don't have a good one.